Global Circulating Tumor Cells Market is Poised to Value USD 19.0 Billion By 2032 | CTC Detection & Enrichment Methods to Hold Dominance Says Astute Analytica
03 avr. 2024 08h30 HE
|
AstuteAnalytica India Pvt. Ltd.
New Delhi, April 03, 2024 (GLOBE NEWSWIRE) -- The global circulating tumor cells market is projected to surpass the market size of US$ 19.0 billion by 2032 from US$ 9.5 billion in 2023 at a CAGR of...
Circulating Tumor Cells Market Projected to Exceed US$ 81.6 Bn by 2033 at CAGR of 19.11% | Marketresearch.biz Report
23 janv. 2024 00h35 HE
|
MarketResearch.biz
New York, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The circulating tumor cells market was valued at USD 14.84 billion in 2023 with significant growth and is projected to reach USD 81.6 billion by 2033 with...
12.3% CAGR, Circulating Tumor Cells Market to Reflect US$ 9.85 Billion by 2030: Reports Insights
27 févr. 2023 06h00 HE
|
REPORTSINSIGHTS CONSULTING PVT LTD
New York, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The Circulating Tumor Cells (CTC) Market is projected to grow at a CAGR of 12.3% from 2023 to 2030, with a value of USD 9.85 Billion by 2030, according to...
Liquid Biopsy Market Size worth $8.12 Bn Globally by 2027 at 9.9% CAGR Says, The Insight Partners
26 juil. 2022 07h34 HE
|
The Insight Partners
New York, July 26, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Liquid Biopsy Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product &...
Circulating Tumor Cells (CTC) Diagnostics Market to Reach US$ 9.5 Billion by 2030 with Attaining 17% CAGR - Fact.MR Report 2022
15 févr. 2022 14h30 HE
|
FACT.MR
ROCKVILLE, Md., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Circulating tumor cells (CTCs) are a blistering topic of oncological conferences and research due to their tremendous potential in the area of...
Liquid Biopsy Market revenue to cross USD 10 Bn by 2027: Global Market Insights Inc.
01 déc. 2021 04h30 HE
|
Global Market Insights, Inc
Selbyville, Delaware, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The liquid biopsy market size is anticipated to record a valuation of USD 10 billion by 2027, according to the most recent study by Global...
Global Breast Cancer Liquid Biopsy Market is Expected to Reach USD 879.41 Million by 2025 : Fior Markets
30 juil. 2019 06h15 HE
|
Fior Markets
New Jersey, NJ, July 30, 2019 (GLOBE NEWSWIRE) -- Fior Markets launched a study titled, "Global Breast Cancer Liquid Biopsy Market by Circulating Biomarkers (Circulating Tumor Cells, Cell-free DNA,...
Zomedica Announces Research Agreement with Celsee Diagnostics for Cancer Liquid Biopsy
05 janv. 2017 06h55 HE
|
Zomedica
ANN ARBOR, Mich., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced it has entered into a...
Atossa Genetics Announces Launch of ArgusCYTE Breast Health Test(SM) for Detection of Circulating Tumor Cells
06 déc. 2011 08h30 HE
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Dec 6, 2011) - Atossa Genetics, Inc., a health care company developing and commercializing a comprehensive set of innovative, proprietary breast health evaluation...